XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues:    
Premiums $ 72,786 $ 64,070
Investment and other income 798 367
Total revenues 91,931 80,149
Operating costs:    
Medical costs 59,845 52,523
Operating costs 13,625 11,401
Cost of products sold 9,405 8,487
Depreciation and amortization 970 788
Total operating costs 83,845 73,199
Earnings from operations 8,086 6,950
Interest expense (754) (433)
Earnings before income taxes 7,332 6,517
Provision for income taxes (1,558) (1,369)
Net earnings 5,774 5,148
Earnings attributable to noncontrolling interests (163) (121)
Net earnings attributable to UnitedHealth Group common shareholders $ 5,611 $ 5,027
Earnings per share attributable to UnitedHealth Group common shareholders:    
Basic $ 6.01 $ 5.34
Diluted $ 5.95 $ 5.27
Basic weighted-average number of common shares outstanding 933 941
Dilutive effect of common share equivalents 10 13
Diluted weighted-average number of common shares outstanding 943 954
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 5 2
Products    
Revenue from Products and Services $ 10,267 $ 9,340
Services    
Revenue from Products and Services $ 8,080 $ 6,372